Microglia actions in Alzheimer’s disease

作者: Stefan Prokop , Kelly R. Miller , Frank L. Heppner

DOI: 10.1007/S00401-013-1182-X

关键词:

摘要: The identification of microglia-associated, neurological disease-causing mutations in patients, combined with studies mouse models has highlighted microglia, the brain’s intrinsic myeloid cells, as key modulators pathogenesis and disease progression neurodegenerative diseases. In Alzheimer’s (AD) particular, activation accumulation microglial cells around β-Amyloid (Aβ) plaques long been described is believed to result chronic neuroinflammation—a term that, despite being commonly used, lacks a precise definition. This seemingly directed response microglia amyloid deposits conflicts fact that increasing buildup Aβ not inhibited by these during progression. While recent evidence suggests lose their beneficial function course AD may even acquire “toxic” phenotype over time, also simply be an appropriate trigger induce phagocytosis degradation vivo. As experimental indicated importance pathogenesis, future efforts aimed at tackling this via utilization or modulation factors therefrom appear exciting challenging research front.

参考文章(172)
S. A. Frautschy, G. M. Cole, A. Baird, Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. American Journal of Pathology. ,vol. 140, pp. 1389- 1399 ,(1992)
Nicholas K. Gonatas, Robert D. Terry, Martin Weiss, ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA. American Journal of Pathology. ,vol. 44, pp. 269- 297 ,(1964)
T C Saido, S A Frautschy, G M Cole, F Yang, M Irrizarry, B Hyman, K Hsiao, Microglial response to amyloid plaques in APPsw transgenic mice. American Journal of Pathology. ,vol. 152, pp. 307- 317 ,(1998)
G. G. Fillenbaum, A. Heyman, Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Neurology. ,vol. 44, pp. 228- 228 ,(2002) , 10.1002/0470846410.CH42(III)
Mausam R. Damani, Lian Zhao, Aurora M. Fontainhas, Juan Amaral, Robert N. Fariss, Wai T. Wong, Age-related alterations in the dynamic behavior of microglia. Aging Cell. ,vol. 10, pp. 263- 276 ,(2011) , 10.1111/J.1474-9726.2010.00660.X
Frédérique Bard, Catherine Cannon, Robin Barbour, Rae-Lyn Burke, Dora Games, Henry Grajeda, Teresa Guido, Kang Hu, Jiping Huang, Kelly Johnson-Wood, Karen Khan, Dora Kholodenko, Mike Lee, Ivan Lieberburg, Ruth Motter, Minh Nguyen, Ferdie Soriano, Nicki Vasquez, Kim Weiss, Brent Welch, Peter Seubert, Dale Schenk, Ted Yednock, Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Medicine. ,vol. 6, pp. 916- 919 ,(2000) , 10.1038/78682
Tony Wyss-Coray, Carol Lin, Fengrong Yan, Gui-Qiu Yu, Michelle Rohde, Lisa McConlogue, Eliezer Masliah, Lennart Mucke, TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nature Medicine. ,vol. 7, pp. 612- 618 ,(2001) , 10.1038/87945
Terrence Town, Yasmina Laouar, Christopher Pittenger, Takashi Mori, Christine A Szekely, Jun Tan, Ronald S Duman, Richard A Flavell, Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology Nature Medicine. ,vol. 14, pp. 681- 687 ,(2008) , 10.1038/NM1781
Donna M. Wilcock, Giovanni DiCarlo, Debbi Henderson, Jennifer Jackson, Keisha Clarke, Kenneth E. Ugen, Marcia N. Gordon, Dave Morgan, Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation The Journal of Neuroscience. ,vol. 23, pp. 3745- 3751 ,(2003) , 10.1523/JNEUROSCI.23-09-03745.2003